|
Model Number 9004 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Swelling (2091)
|
Event Date 08/15/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
The sample was discarded at the user facility: therefore, evaluation was unable to be performed.The product identifiers were obtained; therefore, a device history record (dhr) was reviewed for this device.A lot history review revealed this is the only complaint for this lot.A device history record (dhr) review was performed and noted the device was manufactured to specification prior to being released for distribution.There was nothing found to indicate there was a manufacturing related cause for this event.Conclusion: the actual sample was not received for evaluation.The dhr found nothing to indicate a manufacturing related cause for this event.The hcp treated the target lesion with the lutonix dcb successfully without device malfunction.The patient presented with lower leg swelling during follow up.Diagnostic ultrasound, performed during follow up, ruled out evidence of acute deep vein thrombosis of the target lesion, but could not exclude calf vein thrombosis.The patient was treated with an oral regiment of lasix and additional care instructions for the swollen limb.Based on the information obtained related to the event and the investigation, a definite root cause cannot be determined.Swelling is a known risk of any pta procedure.
|
|
Event Description
|
It was reported a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter allegedly caused lower extremity swelling in the patient, post lutonix dcb treatment.The health care professional (hcp) performed an atherectomy followed by predilation with a normal pta balloon of the patient's right superficial femoral artery (sfa).The hcp treated the target lesion with the lutonix dcb successfully without device malfunction.Approximately two weeks later, the patient presented to the hcp with lower leg swelling.The physician believes the swelling is possibly related to the procedure and products used, including the lutonix dcb.Approximately 2 months later, the patient still had pitting edema and was prescribed lasix 20mg/day for 3-5 days, elevate leg, low salt intake, and to wear a support stocking.A venous ultrasound was conducted and ruled out evidence of acute deep vein thrombosis but could not with certainty exclude isolated calf vein thrombosis.The sample was discarded at the user facility.No further adverse patient effects at this time.
|
|
Search Alerts/Recalls
|
|
|